Accepting applications until August 1
Accepting applications until August 1
Marta Ortega Ortega, Paul Hanly, Alison Pearce, et al. Applied Health Economics and Health Policy (2023) 21:877–889
Between 2018 and 2040, cancer is expected to cause around eight million premature deaths (58% male). The cumulative projected productivity costs in this respect are €1.3 trillion, representing an annual average of €58.7 billion, o... Read More
Cost concerns now rival fear of cancer diagnosis, new survey findsFindings from the Prevent Cancer Foundation’s 2026 Early Detection Survey reveal that concern about unexpected costs of getting routine cancer screenings now rivals... Read More
According to the Prevent Cancer Foundation’s 2025 Early Detection Survey, just 51% of U.S. adults 21 years of age and older say they have had a routine medical appointment or routine cancer screening in the last year.1 This... Read More
There’s been a change in how often U.S. adults are going to routine medical appointments and cancer screenings, and according to the Prevent Cancer Foundation’s 2025 Early Detection Survey, we’re moving in the wrong direction... Read More
November McGarvey, Matthew Gitlin, Ela Fadli,and Karen C. Chung. BMC Health Services Research (2022) 22:1155
Cancer represents a significant source of disease burden in the United States (US), both clinically and economically. Diagnosis and treatment of cancer at earlier stages may reduce this burden. To better understand potential impac... Read More
Sheila R. Reddy, Michael S. Broder, Eunice Chang et al. Current Medical Research and Opinion. Volume 38, Pages 1285-1294 2022
We used 2012–2016 data from the Surveillance, Epidemiology, and End Results (SEER) registry-Medicare claims database to examine cost of care among Medicare beneficiaries with a confirmed cancer diagnosis. From 2012 to 2016, we ide... Read More
Cathy J Bradley, Sara Kitchen, Kelsey M Owsley . J Clin Oncol. 2023 Jun 1;41(16):2939-2948
Approximately 6 million people provide caregiving to people diagnosed with cancer. Many must remain employed to support their household and to have access to health insurance. It is unknown if caregiving for a spouse diagnosed wit... Read More
Tegene Kitaw. Befkad Tilahun, Alemu Zemariam, et al. BMJ Glob Health 2025;10:e017133.
Cancer, a major global health challenge, not only threatens lives but also imposes severe financial burdens, known as ‘financial toxicity’. This strain extends beyond treatment costs to include indirect expenses like lost income a... Read More
Allison W Kurian, Paul Abrahamse, Allison Furgal, et al. JAMA. 2023 Jul 3;330(1):43-51
Germline genetic testing is recommended by practice guidelines for patients diagnosed with cancer to enable genetically targeted treatment and identify relatives who may benefit from personalized cancer screening and prevention. A... Read More
Danielle Brabender, Emily Siegel, Julie O. Culver, et al. Ann Surg Oncol (2025) 32:9041–9049
Only a subset of individuals meeting National Comprehensive Cancer Network (NCCN) guidelines for genetic screening of hereditary cancers are being offered testing. A total of 14,192 women were screened, with 3224 (23%) meeting NCC... Read More
Isabelle A. Lucas Beckett, Kate R. Emery, Josiah T. Wagner. npj Genomic Medicine | (2025) 10:50
Genomic medicine is now at a point where increased sequencing speed, cost reduction, and scalable cloud platforms can enable population-scale clinical sequencing. As 88% of US hospitals are community hospitals, integrating genomic... Read More
Juliann M Savatt 1, Melissa A Kelly 1, Amy C Sturm 1 2, Cara Z McCormick . JAMA Netw Open. 2025 Mar 3;8(3):e250917
Completion of the Human Genome Project prompted predictions that genomics would transform medicine, including through genomic screening that identifies potentially medically actionable findings that could prevent disease, detect i... Read More